Related references
Note: Only part of the references are listed.Fabrication process development and basic evaluation of eggshell-based column packing material for reversed-phase preparative separation
Tomoka Yoshii et al.
JOURNAL OF CHROMATOGRAPHY A (2023)
Quantitative evaluation of reversed-phase packing material based on calcium carbonate microspheres modified with an alternating copolymer
Kogi Kaizu et al.
JOURNAL OF CHROMATOGRAPHY A (2022)
Development of PM10 and PM2.5 cyclones for small sampling ports at stationary sources: Numerical and experimental study
Jong-Sang Youn et al.
ENVIRONMENTAL RESEARCH (2021)
Thermosensitive molecularly imprinted poly(1-vinyl-2-pyrrolidone/methyl methacrylate/N-vinylcaprolactam) for selective extraction of imatinib mesylate in human biological fluid
Atefeh Kazemi et al.
JOURNAL OF SEPARATION SCIENCE (2020)
On-Site Therapeutic Drug Monitoring
H. Ceren Ates et al.
TRENDS IN BIOTECHNOLOGY (2020)
A biomimetic hybrid material consisting of CaCO3 mesoporous microspheres and an alternating copolymer for reversed-phase HPLC
Mai Mochida et al.
JOURNAL OF MATERIALS CHEMISTRY B (2019)
Hierarchical CaCO3 Chromatography: A Stationary Phase Based on Biominerals
Kosuke Sato et al.
CHEMISTRY-A EUROPEAN JOURNAL (2015)
Comparison of conventional liquid chromatography-tandem mass spectrometry versus microflow liquid chromatography-tandem mass spectrometry within the framework of full method validation for simultaneous quantification of 40 antidepressants and neuroleptics in whole blood
Andrea E. Steuer et al.
JOURNAL OF CHROMATOGRAPHY A (2015)
Therapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspective
Michel Laverdiere et al.
CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY (2014)
Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology
H. Ruth Ashbee et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Prioritising anticancer drugs for environmental monitoring and risk assessment purposes
Victoria Booker et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2014)
Therapeutic drug monitoring of antimicrobials
Jason A. Roberts et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Quantitative Determination of Imatinib in Human Plasma with High-Performance Liquid Chromatography and Ultraviolet Detection
Masatomo Miura et al.
JOURNAL OF CHROMATOGRAPHIC SCIENCE (2011)
Optimization of the simultaneous determination of imatinib and its major metabolite, CGP74588, in human plasma by a rapid HPLC method using D-optimal experimental design
Ali-Akbar Golabchifar et al.
TALANTA (2011)
Imatinib assay by HPLC with photodiode-array UV detection in plasma from patients with chronic myeloid leukemia: Comparison with LC-MS/MS
Olivia Roth et al.
CLINICA CHIMICA ACTA (2010)
Validation of an HPLC Method for Determination of Imatinib Mesylate in Rat Serum and Its Application in a Pharmacokinetic Study
Girish Bende et al.
JOURNAL OF CHROMATOGRAPHIC SCIENCE (2010)
Some new selective stationary phases for RP-HPLC
Isabel C. S. F. Jardim et al.
JOURNAL OF SEPARATION SCIENCE (2010)
Determination of imatinib plasma levels in patients with chronic myeloid leukemia by high performance liquid chromatography-ultraviolet detection and liquid chromatography-tandem mass spectrometry: Methods' comparison
Abdalla Awidi et al.
LEUKEMIA RESEARCH (2010)
New HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma
Silvia De Francia et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2009)
The combined effect of silanols and the reversed-phase ligand on the retention of positively charged analytes
UD Neue et al.
JOURNAL OF CHROMATOGRAPHY A (2005)
Imatinib: a selective tyrosine kinase inhibitor
PW Manley et al.
EUROPEAN JOURNAL OF CANCER (2002)
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
GD Demetri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Glivec (ST1571, Imatinib), a rationally developed, targeted anticancer drug
R Capdeville et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Share Paper
